The Center for Substance Abuse Treatment (CSAT), part of the Substance Abuse & Mental Health Services Administration (SAMHSA), has three new grant opportunities. The first, Grants to Expand Care Coordination Targeted Capacity Expansion (TCE) through the Use of Technology Assisted Care (TAC) in Targeted Areas of Need, will make approximately 13 awards of up to $280,000 per year for three years for applicants proposing to enhance and/or expand the capacity of substance use disorder treatment providers for youth and adults with substance use disorders or co-occurring substance use and mental health disorders who are underserved and/or have special needs (elderly, racial minorities, criminal justice involved individuals, etc.). Applications are due January 4, 2016.

The second CSAT opportunity, Screening, Brief Intervention, and Referral to Treatment (SBIRT) Health Professions Student Training, is seeking applications for the development and implementation of training programs to teach students in health professions (physician assistants, dentists, psychologists, pharmacists, nurses, social workers, counselors, and medical students and residents) the skills necessary to provide evidence-based screening and brief intervention and refer patients who are at risk for a substance use disorder to appropriate treatment. SAMHSA anticipates making approximately 12 awards of up to $290,000 per year for three years. Applications are due January 4, 2016.

In addition, CSAT has opened its Cooperative Agreement for the Provider’s Clinical Support System – Medication Assisted Treatment (PCSS-MAT) opportunity. This program builds on the Drug Addiction Treatment Act of 2000 and SAMHSA’s currently funded PCSS-MAT to increase the number of healthcare providers to address the nation’s lack of adequate care. Eligibility is limited to the national professional medical organizations authorized by the Drug Addiction Treatment Act of 2000 (DATA) to carry out the training of providers desiring to prescribe and/or dispense FDA approved schedule III medications for the addictive disorders. There will be one award of $1 million per year for three years. Applications are due January 11, 2016.